Status: current, Defined. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2116431000168115 | Hexaxim (Bordetella pertussis filamentous haemagglutinin antigen 25 microgram + Bordetella pertussis toxoid 25 microgram + diphtheria toxoid 20 international units + Haemophilus influenzae serotype b conjugate (polyribosylribitol phosphate to tetanus toxoid) antigen 12 microgram + hepatitis B surface antigen 10 microgram + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection suspension, 1 x 0.5 mL syringe (trade product pack) | en | Fully specified name | Inactive | Case sensitive | Australian Medicines Terminology module |
| 2116441000168112 | Hexaxim injection suspension, 0.5 mL syringe | en | Synonym | Inactive | Case sensitive | Australian Medicines Terminology module |
| 3111251000168112 | Hexaxim (Bordetella pertussis filamentous haemagglutinin antigen 25 microgram + Bordetella pertussis toxoid 25 microgram + diphtheria toxoid 20 international units + Haemophilus influenzae serotype b conjugate (polyribosylribitol phosphate to tetanus toxoid) antigen 12 microgram + hepatitis B surface antigen 10 microgram + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 1 x 0.5 mL syringe (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3111261000168114 | Hexaxim injection, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hexaxim injection, 0.5 mL syringe | Is a | diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe | true | Inferred relationship | Some | ||
| Hexaxim injection, 0.5 mL syringe | Is a | trade product pack | true | Inferred relationship | Some | ||
| Hexaxim injection, 0.5 mL syringe | has TPUU | Hexaxim injection, 0.5 mL syringe | true | Inferred relationship | Some | 1 | |
| Hexaxim injection, 0.5 mL syringe | has TP | Hexaxim | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hexaxim injection, 0.5 mL syringe | Is a | True | Hexaxim injection, 0.5 mL syringe | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
Trade product pack reference set
FHIR